Arthur Fratamico serves as Executive at Vitae Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Arthur Fratamico has executed 6 insider transactions totaling $78.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 25, 2021 involved receiving (via award) 4,316 shares valued at $0.
Arthur Fratamico currently holds 9,615 shares of Vitae Pharmaceuticals, Inc (VTAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Fratamico has been a net buyer of VTAE stock. They have purchased $78.3K and sold $0 worth of shares.
Arthur Fratamico's most recent insider trade was on May 25, 2021, when they sold 4,316 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 1, 2020 | SNBP | $0 | Purchase | 2,424 | $N/A | Discretionary |
| Oct 24, 2016 | VTAE | $277.9K | Tender | 13,233 | $21.00 | Discretionary |
| Apr 29, 2016 | VTAE | $12.7K | Award | 2,086 | $6.11 | Discretionary |
| Aug 27, 2015 | VTAE | $78.3K | Purchase | 10,000 | $7.83 | Discretionary |